Behandling af pædiatriske patienter med recidiverende eller refraktær akut lymfoid leukæmi (ALL), efter at de har fået mindst to tidligere behandlingsregimer, og hos hvem ingen andre behandlings - former forventes at kunne opnå et varigt respons.
Treatment of acute lymphoblastic leukaemia (ALL) in paediatric patients who have relapsed or are refractory after receiving at least two prior regimens and where there is no other treatment option anticipated to result in a durable response.